COVID-19 Vaccine Prepositioning Site
CDC is asking all jurisdictions to identify sites that may be used to pre-position COVID-19 vaccines to ensure that supply is closer to the administration site where vaccines are needed once Food and Drug Administration (FDA) issues an Emergency Use Authorization (EUA) and Advisory Committee on Immunization Practices (ACIP) recommendations are made. This pre-positioning is a onetime effort intended to shorten the timeline between EUA release and the initiation of vaccine administration.
To determine if your facility/site is a candidate for pre-positioning of COVID-19 vaccine, all 4 of the following conditions must be met:
- Have ultra-cold (-60 deg C to -80 deg C) freezer storage.
- Can serve front line health care workers.
- Can store, handle, and monitor ultra-cold temperature vaccine.
- Sites selected for this one-time shipment, should not be dependent on dry ice or thermal coolers for storage.